Otsuka Holdings Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Otsuka Holdings Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Otsuka Holdings Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Otsuka Holdings Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Otsuka Holdings Co Ltd (Otsuka) is a holding company that operates various businesses such as pharmaceuticals, nutraceuticals, consumer products, and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions, and allergies. The company’s product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, fine chemicals, electronic equipment, functional chemicals, medical devices, and OTC products. The company markets its products across North America, Europe, and Asia. Otsuka is headquartered in Minato-ku, Tokyo, Japan.
Headquarters
Japan
Address
2-16-4, Konan, Shinagawa Grand Central Tower, Minato, Tokyo, 108-8241
Website
www.otsuka.com/jp
Telephone
81 3 67171410
No of Employees
37,758
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4578 (TYO)
Revenue (2024)
$15.9B
6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
5.8%
(2024 vs 2023)
Market Cap*
$36.8B
Net Profit Margin (2024)
XYZ
-0.1%
(2024 vs 2023)
* As of and is in US$
Otsuka Holdings Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Pharmaceuticals: | Warehousing | Abilify Maintena |
| Anti-psychotic | Transportation | Abilify |
| Anti-platelet Agents | Sprycel | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Regulatory Approval | In May, the company's subsidiary Taiho Pharma received approval from the US FDA for Inqovi, for the treatment of Acute Myeloid Leukemia. |
| 2026 | Contracts/Agreements | In February, the company entered into an agreement with Jera Cross Co Inc to procure renewable electricity from solar energy. |
| 2026 | New Products/Services | In February, the company launched 100kcal My Size Chicken Curry and 100kcal My Size Gapao. |
Competitor Comparison
| Key Parameters | Otsuka Holdings Co Ltd | Astellas Pharma Inc | Daiichi Sankyo Co Ltd | Chugai Pharmaceutical Co Ltd | Taisho Pharmaceutical Holdings Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Minato | Chuo-Ku | Chuo-Ku | Chuo-Ku | Toshima |
| State/Province | Tokyo | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 37,758 | 13,643 | 19,765 | 7,872 | 8,784 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ichiro Otsuka | Chairman | Executive Board | 2015 | 60 |
| Yuko Makino | Director; Chief Financial Officer | Executive Board | 2019 | 64 |
| Makoto Inoue | Chief Executive Officer; President | Senior Management | 2025 | 67 |
| Yoshiro Matsuo | Executive Vice President; Director | Executive Board | 2025 | 65 |
| Nobuyuki Kurahashi | Senior Executive Vice President - Pharmaceutical Business Group; Associate General Manager; Operating Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer